Home > Income Statement > CONCORD BIOTECH

CONCORD BIOTECH
Revenue

    Back to Income Statement
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹1,017 Cr₹853 Cr₹71 Cr₹617 Cr₹5,123 Cr

What is the latest Revenue of CONCORD BIOTECH ?

The latest Revenue ratio of CONCORD BIOTECH is ₹1,017 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹1,017 Cr
Mar2024₹853 Cr
Mar2023₹71 Cr
Mar2022₹617 Cr
Mar2021₹5,123 Cr

How is Revenue of CONCORD BIOTECH Trending?

Years Revenue % Change
Mar2025 ₹1,017 Cr
19.20
Mar2024 ₹853 Cr
1,096.71
Mar2023 ₹71 Cr
-88.44
Mar2022 ₹617 Cr
-87.96
Mar2021 ₹5,123 Cr -

Compare Revenue of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹13,878.9 Cr 7.2% 10.7% -32.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,785.0 Cr 0.4% -4.6% 6.9% Stock Analytics
DIVIS LABORATORIES ₹176,242.0 Cr 0.7% -1.1% 2.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹151,058.0 Cr 2.9% -1.2% 42.7% Stock Analytics
CIPLA ₹111,180.0 Cr -1.5% 5.5% -6.5% Stock Analytics
DR REDDYS LABORATORIES ₹106,149.0 Cr 0.4% -0.6% 1.3% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

7.2%

10.7%

-32.3%

SENSEX

-0.5%

-4.3%

-8.4%


You may also like the below Video Courses